Cellforcure Information

CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE facility is the first modular entity in Europe to enable large scale industrial production for ATMPs. This platform operates on a mixed model of a CDMO (Contract Development and Manufacturing Organisation) providing large scale GMP and cGMP production services, for both clinical and commercial needs, and of a pharmaceutical company leading the development of cell and gene therapies medicinal products up to their launch on the market. CELLforCURE is an LFB subsidiary.

Website	https://www.novartis.fr/notre-travail/notre-site-des-ulis
Revenue	$7 million
Employees	104 (19 on RocketReach)
Founded	2010
Address	3 Ave Des Tropiques - Bp 305 Les Ulis - Zone D'Activités De Courtaboeuf, Les Ulis, Ile-de-France 91940, FR
Phone	+33 1 69 82 17 21
Technologies	Proofpoint , Akamai DNS (view technologies)
Industry	Biotechnology, Drug Manufacturing & Research, Pharmaceuticals, Science and Engineering, Healthcare
Web Rank	8 Million
Keywords	Cell Therapy, Gene Therapy, Cellular Therapies, Gene Therapies, Regenerative Medicine, Advanced Therapy Medicinal Products, Atmp, Biologics Manufacturing, Pharmaceutical Manufacturing, Drug Development, Bioprocessing, Cell Culture, Gene Editing, Viral Vectors, Immunotherapy, Oncology, Rare Diseases, Clinical Trials, Pharmaceutical Production, Biotechnology
Competitors	Thermo Fisher Scientific, AbbVie, Boehringer Ingelheim, Merck KGaA, Darmstadt, Germany, FUJIFILM Diosynth Biotechnologies, Charles River Laboratories, Lonza, Cytiva, Sartorius, Genzyme Europe B.V. +43 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies